Psychemedics Corporation Announces New Vice President of Sales

ACTON, Mass., April 7 /PRNewswire-FirstCall/ -- Psychemedics Corporation (Nasdaq: PMD) today announced the appointment of James V. Dyke as the Company's new Vice President of Sales.  In this position, Mr. Dyke will be responsible for all sales activities and be a key member of the management team in developing the Company's strategic plans.

Mr. Dyke brings to Psychemedics Corporation a broad experience in sales and marketing; and also has general management experience.  Prior to joining Psychemedics, Mr. Dyke served as Vice President of Sales for the Document Messaging Technologies (DMT) operation of Pitney Bowes Corporation.  Immediately preceding that assignment, Mr. Dyke was the General Manager for the UK and Ireland Document Messaging Technologies business.  Previous positions also held were General Manager and division Vice President for Pitney Bowes DMT Canada, as well as additional sales assignments in channel management, branch management and major accounts in over a 23 year career, primarily with Pitney Bowes.  

Raymond Kubacki, Chairman and CEO stated, "We are extremely excited about having Jim join our team.  We look forward to drawing upon his rich experience to help us accelerate our sales growth as Psychemedics continues to offer to corporations, both nationally and globally, the most effective test for illegal drugs of abuse."

Psychemedics is the world's largest provider of testing for drugs of abuse using hair analysis with thousands of corporations relying on the patented Psychemedics drug testing services.  Psychemedics' clients include over 10% of the Fortune 500, some of the largest police departments in America and Federal Reserve Banks.

The Psychemedics web site is www.drugtestwithhair.com.

SOURCE Psychemedics Corporation